糖抗原125(CA125)重組蛋白
Recombinant Carbohydrate Antigen 125 (CA125)
MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125
- 編號(hào)RPA154Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量-
- 實(shí)際分子量-(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)-
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1536¥ 3840¥ 7680¥ 23040¥ 57600
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
PBS或其它。
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA154Mu01 | 糖抗原125(CA125)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA154Mu02 | 糖抗原125(CA125)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA154Mu02 | 糖抗原125(CA125)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA154Mu01 | 糖抗原125(CA125)多克隆抗體 | WB; IHC. |
| PAA154Mu02 | 糖抗原125(CA125)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA154Mu71 | 糖抗原125(CA125)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEA154Mu | 糖抗原125(CA125)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA154Mu | 糖抗原125(CA125)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| PLoS One | Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice.[pubmed:27755542] |
| Tumor Biology | KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis[pubmed:28651492] |
| Oncotarget | Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer[Pubmed:29484129] |
| Prognostic value of STC1 expression in ovarian cancer[] | |
| American Journal of Translational Research | Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway[Pubmed:35422913] |